Joel Neugarten is a Nephrology physician affiliated with Albert Einstein College of Medicine. OpenAlex indexes 109 publications with 6,201 citations (h-index 45); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Medical Arts Pavilion
3400 Bainbridge Avenue
Bronx, NY 10467
Telephone
718-920-7564Registry record last updated 8 Jul 2007.
Clinical trials
- Measurement of Renal Function With Iohexol in Subjects Ingesting Carnitine
Sponsor: Montefiore Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20253 payments
- Otsuka America Pharmaceutical, Inc.Program year20252 payments
- Vifor Pharma, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.9%Calcium channel blocker18.8%Nifedipine Er65%Amlodipine Besylate32%Diltiazem 24hr Er (Cd)3%Part D<11 patientsLoop diuretic10%Furosemide86%Torsemide14%Part D<11 patients+ 11 more classes in this area
Metabolism & gastrointestinal
16.3%SGLT2 inhibitor4.7%Farxiga61%Jardiance39%Part D≥26 patientsProvitamin D2 Compound4%Vitamin D2100%Part D≥30 patients+ 9 more classes in this area
Other
4.7%Drugs for treatment of hyperkalemia and hyperphosphatemia2%Lokelma100%Part D≥17 patientsPhosphate Binder1.8%Sevelamer Carbonate100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- AKI in Hospitalized Patients with and without COVID-19: A Comparison Study
Journal of the American Society of Nephrology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Lipton, MD
Albert Einstein College of Medicine
Marina Konopleva, MD, PhD
Albert Einstein College of Medicine
Solomon Moshe, MD
Albert Einstein College of Medicine
Shlomo Shinnar, MD, PhD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”